Thomas G P, Varma R K
Department of Pharmacology, IDPL Research Centre, Hyderabad, India.
Pharmacol Res. 1993 May-Jun;27(4):365-71. doi: 10.1006/phrs.1993.1036.
Flutonidine (10, 20 and 40 micrograms/kg) was studied for its efficacy against the cardiotoxic effects induced by slow intravenous infusion of ouabain in guinea-pigs. Flutonidine increased the dose of ouabain required to cause ventricular premature beats, ventricular tachyarrhythmias and lethality. Flutonidine further inhibited the rate of ouabain-induced rise in blood pressure. Alpha 1 adrenoceptor antagonist, corynanthine (1 mg/kg), could not alter the protective action of flutonidine; whereas idazoxan (100 micrograms/kg), the alpha 2 adrenoceptor blocker, showed significant inhibition of this effect. It is suggested that the reduction in the arrhythmogenic and lethal effects of ouabain by flutonidine may be due to its ability to reduce sympathetic tone by interfering with the neural components of ouabain action mediated through alpha 2 adrenoceptors.
研究了氟托尼定(10、20和40微克/千克)对豚鼠缓慢静脉注射哇巴因所致心脏毒性作用的疗效。氟托尼定增加了引起室性早搏、室性快速心律失常和致死所需的哇巴因剂量。氟托尼定进一步抑制了哇巴因诱导的血压升高速率。α1肾上腺素能受体拮抗剂育亨宾(1毫克/千克)不能改变氟托尼定的保护作用;而α2肾上腺素能受体阻滞剂咪唑克生(100微克/千克)则显著抑制了这种作用。提示氟托尼定降低哇巴因致心律失常和致死作用可能是由于其通过干扰由α2肾上腺素能受体介导的哇巴因作用的神经成分来降低交感神经张力的能力。